Early invasive cancer of the breast. Clinico-pathological analysis for establishment a new disease entity
Early invasive cancer of the breast. Clinico-pathological analysis for establishment a new disease entity
批准号:
12670153
负责人:
MORIYA Takuya
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Most of the cases of invasive ductal carcinoma (IDC) of the breast may be developed through the stage of in situ carcinoma (DCIS). Thus we have analyzed the "early" invasive carcinomas to clarify the pathogenesis and clinical significances of these lesions. (1) Clinicopathological review of the minimally invasive (less than 1 mm) carcinomas revealed that their noninvasive components were mainly composed by comedo architecture and high nuclear grade. Lymph node metastatic status was not different from pure DCISs. (2) Invasive micropapillary carcinoma, which is a spacial type of breast carcinoma with poor prognosis were examined. They were also showed high nuclear grade, higher number of lymph node metastasis frequently, and prognosis were not so good by more than 3 years follow-up. As this special type cancer is not expanding through the duct-lobular system extensively, this will be one of the model of invasive carcinoma with earlier event of distant metastasis. Cytological analysis revealed that some of the characteristic findings. There is a possibility that we can detect this type earlier by fine needle aspiration cytology. (3) We have done the LOH analysis by 13 of well known microsatellite markers to check the early event of carcinoma invasion. IDC had the same pattern of LOH with the s DCIS and atypical hyperplasia in the same operated material. Additionaly, there were the same LOH pattern between IDC and previously biopsied DCIS. Thus it may reasonable to consider the possibility that the genetic change of IDC had been occurred earlier than the early invasion of carcinoma.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Suzuki T, Moriya T, et al.: "Retinoid receptors in human breast carcinoma. Possible modurators of in situ estrogen metabolism"Br. J. Cancer. 65. 31-40 (2001)
Suzuki T、Moriya T 等人:“人类乳腺癌中的类视黄醇受体。原位雌激素代谢的可能调节剂”Br。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki T, Darnel AD, Moriya T, Sasano H, et al.: "5 α-reductases in human breast carcinoma : Possible modulator of in situ androgenic actions"J. Clin. Endocrin. Metabol.. 66. 2250-2257 (2001)
Suzuki T、Darnel AD、Moriya T、Sasano H 等人:“人乳腺癌中的 5 种 α-还原酶:原位雄激素作用的可能调节剂”J. Clin Metabol. 66。 2250-2257 )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Moriya T: "Noninvasive ductal carcinoma and borderline malignancy of the breast"Tohoku Med. J.. 113. 155-157 (2002)
Moriya T:“非浸润性导管癌和乳腺交界性恶性肿瘤”Tohoku Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Moriya T, Ohuchi N, Sasano H: "Atypical ductal hyperplasia (ADH)"Basic Research and Clinical Medicine of Intraductal Carcinoma of the Breast. Shinohara Syuppan Shinsya, Tokyo. 57-64 (2001)
Moriya T,Ohuchi N,Sasano H:“非典型导管增生(ADH)”乳腺癌导管内癌的基础研究和临床医学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki T, Moriya T, et al.: "5 α-reductase in human breast carcinoma. Possible moudurator of in situ androgenic actions"J.Clin.Endocrin.Metabol. 85(5). 2250-2257 (2001)
Suzuki T、Moriya T 等人:“人乳腺癌中的 5 α-还原酶。原位雄激素作用的可能调节剂”J.Clin.Endocrin.Metabol。85(5) 2250-2257 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 51 条
Precancerous lesion of the breast: Establishment of disease entity and verification of clinic-pathological significance
-
批准号:22590340
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:MORIYA Takuya
-
依托单位:
EARLY INVASIVE BREAST CANCER. ANALYSIS OF CLINICOPATHOLOGICAL PARAMETERS CORRELATED WITH EARLY METASTASIS
-
批准号:16590266
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:MORIYA Takuya
-
依托单位:
海外基金